FDA accepts NDA submission for Anaphylm; PDUFA date set for January 31, 2026Planning continues for a Q1 2026 U.S. launch of Anaphylm, if approved by the FDACompany accelerates Anaphylm global expansio ...

If you provide what people want, at the right price, and keep innovating your product, ensuring that you staff are well ...